MacFarlane GD - Search Results

1

Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level.

Vieth R, Chan PC, MacFarlane GD. Vieth R, et al. Among authors: macfarlane gd. Am J Clin Nutr. 2001 Feb;73(2):288-94. doi: 10.1093/ajcn/73.2.288. Am J Clin Nutr. 2001. PMID: 11157326 Clinical Trial.

2

Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer.

Ersfeld DL, Rao DS, Body JJ, Sackrison JL Jr, Miller AB, Parikh N, Eskridge TL, Polinske A, Olson GT, MacFarlane GD. Ersfeld DL, et al. Among authors: macfarlane gd. Clin Biochem. 2004 Oct;37(10):867-74. doi: 10.1016/j.clinbiochem.2004.06.006. Clin Biochem. 2004. PMID: 15369717

3

Hypovitaminosis D in a normal, apparently healthy urban European population.

MacFarlane GD, Sackrison JL Jr, Body JJ, Ersfeld DL, Fenske JS, Miller AB. MacFarlane GD, et al. J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):621-2. doi: 10.1016/j.jsbmb.2004.03.042. J Steroid Biochem Mol Biol. 2004. PMID: 15225851

4

Evaluation of 25 OH Vitamin D in chronic renal failure and end stage renal disease subjects.

MacFarlane GD, Sackrison JL, Ersfeld DL, Miller AB, Bucklen A. MacFarlane GD, et al. J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):619-20. doi: 10.1016/j.jsbmb.2004.03.041. J Steroid Biochem Mol Biol. 2004. PMID: 15225850

5

Therapeutic drug monitoring of tacrolimus in pediatric liver transplant patients.

MacFarlane GD, Venkataramanan R, McDiarmid SV, Pirsch JD, Scheller DG, Ersfeld DL, Fitzsimmons WE. MacFarlane GD, et al. Pediatr Transplant. 2001 Apr;5(2):119-24. doi: 10.1046/j.1397-3142.2000.00000.x. Pediatr Transplant. 2001. PMID: 11328550

6

Analytical validation of the PRO-Trac II ELISA for the determination of tacrolimus (FK506) in whole blood.

MacFarlane GD, Scheller DG, Ersfeld DL, Shaw LM, Venkatarmanan R, Sarkozi L, Mullins R, Fox BR. MacFarlane GD, et al. Clin Chem. 1999 Sep;45(9):1449-58. Clin Chem. 1999. PMID: 10471647 Clinical Trial.

7

Analysis of whole blood tacrolimus concentrations in liver transplant patients exhibiting impaired liver function.

MacFarlane GD, Shaw LM, Venkataramanan R, Mullins R, Scheller DG, Ersfeld DL. MacFarlane GD, et al. Ther Drug Monit. 1999 Dec;21(6):585-92. doi: 10.1097/00007691-199912000-00001. Ther Drug Monit. 1999. PMID: 10604816 Clinical Trial.

8

Analytical and clinical validation of a radioimmunoassay for the measurement of 1,25 dihydroxy vitamin D.

Clive DR, Sudhaker D, Giacherio D, Gupta M, Schreiber MJ, Sackrison JL, MacFarlane GD. Clive DR, et al. Among authors: macfarlane gd. Clin Biochem. 2002 Oct;35(7):517-21. doi: 10.1016/s0009-9120(02)00378-8. Clin Biochem. 2002. PMID: 12493579

9

A simplified whole blood enzyme-linked immunosorbent assay (ProTrac II) for tacrolimus (FK506) using proteolytic extraction in place of organic solvents.

MacFarlane G, Scheller D, Ersfeld D, Jensen T, Jevans A, Wong PY, Kobayashi M. MacFarlane G, et al. Ther Drug Monit. 1996 Dec;18(6):698-705. doi: 10.1097/00007691-199612000-00012. Ther Drug Monit. 1996. PMID: 8946668

10

Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients.

Venkataramanan R, Shaw LM, Sarkozi L, Mullins R, Pirsch J, MacFarlane G, Scheller D, Ersfeld D, Frick M, Fitzsimmons WE, Virji M, Jain A, Brayman KL, Shaked A. Venkataramanan R, et al. J Clin Pharmacol. 2001 May;41(5):542-51. doi: 10.1177/00912700122010429. J Clin Pharmacol. 2001. PMID: 11361051 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results